Browsing by Author "Makris, Michael"

Sort by: Order: Results:

  • Kolkhir, Pavel; Altrichter, Sabine; Asero, Riccardo; Daschner, Alvaro; Ferrer, Marta; Giménez Arnau, Anna Maria; Hawro, Tomasz; Jakob, Thilo; Kinaciyan, Tamar; Kromminga, Arno; Konstantinou, George N.; Makris, Michael; Metz, Martin; Skov, Per Stahl; Staubach, Petra; Sussman, Gordon; Zhang, Ke; Maurer, Marcus (Korean Academy of Asthma, Allergy and Clinical ImmunologyKorean Academy of Pediatric Allergy and Respiratory Disease, 2021)
    Purpose: Patients with chronic spontaneous urticaria (CSU) have an increased risk for comorbid autoimmune diseases. In this retrospective multicenter study of CSU patients, we evaluated clinical and laboratory features of ...
  • Maurer, Marcus; Metz, Martin; Bindslev Jensen, Carsten; Bousquet, Jean; Canonica, G. Walter; Church, Martin K.; Godse, Kiran V.; Grattan, Clive; Hide, Michihiro; Kocatürk, Emek; Magerl, M.; Makris, Michael; Meshkova, R. Y.; Saini, Sarbjit S.; Sussman, Gordon; Toubi, Elias; Zhao, Zuotao; Zuberbier, Torsten; Giménez Arnau, Anna Maria (Wiley, 2016)
    BACKGROUND: GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy ...
  • Maurer, Marcus; Giménez Arnau, Anna Maria; Bernstein, Jonathan A.; Chu, Chia-Yu; Danilycheva, Inna; Hide, Michihiro; Makris, Michael; Metz, Martin; Savic, Sinisa; Sitz, Karl; Soong, Weily; Staubach, Petra; Sussman, Gordon; Barve, Avantika; Burciu, Alis; Hua, Eva; Janocha, Reinhold; Severin, Thomas (Wiley, 2022)
    Background: Ligelizumab, a next-generation, humanized anti-immunoglobulin E (IgE) monoclonal antibody is in development as a treatment for patients with chronic spontaneous urticaria, whose symptoms are inadequately ...

Search DSpace


My Account

In collaboration with Compliant to Partaking